                         SEQUENCE LISTING

<110>  THERATECHNOLOGIES INC.
       POTVIN, Diane
 
<120>  ASSESSMENT OF IGF-1 LEVELS IN HIV-INFECTED SUBJECTS AND USES 
       THEREOF

<130>  11718.311

<150>  US 61/432,659
<151>  2011-01-14

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  70
<212>  PRT
<213>  Homo sapiens

<400>  1

Gly Pro Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln Phe 
1               5                   10                  15      


Val Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly Tyr Gly 
            20                  25                  30          


Ser Ser Ser Arg Arg Ala Pro Gln Thr Gly Ile Val Asp Glu Cys Cys 
        35                  40                  45              


Phe Arg Ser Cys Asp Leu Arg Arg Leu Glu Met Tyr Cys Ala Pro Leu 
    50                  55                  60                  


Lys Pro Ala Lys Ser Ala 
65                  70  


<210>  2
<211>  44
<212>  PRT
<213>  Homo sapiens

<400>  2

Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg Gln Gln Gly 
            20                  25                  30          


Glu Ser Asn Gln Glu Arg Gly Ala Arg Ala Arg Leu 
        35                  40                  


<210>  3
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tyr residue at position is linked to a trans-3-hexenoyl moiety

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  Leu residue at position 44 is capped with an unsubstituted amide 
       moiety

<400>  3

Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg Gln Gln Gly 
            20                  25                  30          


Glu Ser Asn Gln Glu Arg Gly Ala Arg Ala Arg Leu 
        35                  40                  


